Alumis, Inc. (ALMS)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$11.10-2.29%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · ALMS
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | |
|---|---|---|---|---|---|
| Revenues | |||||
| Revenues | 7.4 | 24.1 | — | — | — |
| Operating Expenses & Income | |||||
| R&D Expenses | 347.5 | 386.0 | 265.6 | 137.7 | — |
| Operating Income | (459.0) | (453.8) | (300.8) | (158.2) | — |
| Earnings from Continuing Operations | |||||
| Other Non-Operating Income / Expenses | 18.3 | 201.9 | 6.5 | 3.2 | — |
| Asset Writedown | — | 0.5 | — | — | — |
| EBT, Incl. Unusual Items | — | (251.9) | — | — | — |
| Income Tax Expense | — | (8.6) | — | 0.0 | — |
| Net Income | |||||
| Net Income | (439.0) | (243.3) | (294.2) | (155.0) | — |
| Per Share | |||||
| Basic EPS | (3.44) | (2.86) | (10.38) | (72.08) | — |
| Diluted EPS | (3.44) | (2.86) | (10.38) | (72.08) | — |
| Revenue per Share | 0.06 | — | — | — | — |
| Basic Weighted Avg Shares | 127.7 | 85.0 | 28.3 | 2.2 | — |
| Diluted Weighted Avg Shares | 127.7 | 85.0 | 28.3 | 2.2 | — |
| Supplemental | |||||
| EBITDA | — | (450.3) | (297.6) | (156.9) | — |
| EBIT | (459.0) | (453.8) | (300.8) | (158.2) | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.